Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Barton

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Frontiers in Cardiovascular Medicine|December 15, 2015
Advancing and Translating Knowledge in Vascular MedicineMarc Husmann, Matthias Barton
Expert Opinion on Investigational Drugs|April 28, 2007
Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular diseaseMarc Husmann, Matthias Barton
Current Hypertension Reports|March 28, 2008
Fat intake and cardiovascular responseMarlen Damjanovic, Matthias Barton
Expert Opinion on Investigational Drugs|October 31, 2003
Cardiovascular consequences of the obesity pandemic: need for actionMatthias Barton, Jörg Furrer
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Endothelin: 20 years from discovery to therapyMatthias Barton, Masashi Yanagisawa
Cardiovascular Research|July 24, 2020
Exercise is medicine: key to cardiovascular disease and diabetes preventionMatthias Barton, Carmine Cardillo
Molecular and Cellular Endocrinology|February 18, 2014
Estrogen biology: new insights into GPER function and clinical opportunitiesEric R Prossnitz, Matthias Barton
Contributions to Nephrology|September 7, 2011
Endothelin antagonists in clinical trials: lessons learnedMatthias Barton, Donald E Kohan
Cardiovascular Research|June 23, 2009
ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosisMatthias R Meyer, Matthias Barton
Prostaglandins & Other Lipid Mediators|May 16, 2009
Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPEREric R Prossnitz, Matthias Barton
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Frontiers in Cardiovascular Medicine|December 15, 2015
Advancing and Translating Knowledge in Vascular MedicineMarc Husmann, Matthias Barton
Expert Opinion on Investigational Drugs|April 28, 2007
Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular diseaseMarc Husmann, Matthias Barton
Current Hypertension Reports|March 28, 2008
Fat intake and cardiovascular responseMarlen Damjanovic, Matthias Barton
Expert Opinion on Investigational Drugs|October 31, 2003
Cardiovascular consequences of the obesity pandemic: need for actionMatthias Barton, Jörg Furrer
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Endothelin: 20 years from discovery to therapyMatthias Barton, Masashi Yanagisawa
Cardiovascular Research|July 24, 2020
Exercise is medicine: key to cardiovascular disease and diabetes preventionMatthias Barton, Carmine Cardillo
Molecular and Cellular Endocrinology|February 18, 2014
Estrogen biology: new insights into GPER function and clinical opportunitiesEric R Prossnitz, Matthias Barton
Contributions to Nephrology|September 7, 2011
Endothelin antagonists in clinical trials: lessons learnedMatthias Barton, Donald E Kohan
Cardiovascular Research|June 23, 2009
ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosisMatthias R Meyer, Matthias Barton
Prostaglandins & Other Lipid Mediators|May 16, 2009
Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPEREric R Prossnitz, Matthias Barton
Pageof 15